Blumberg Institute Names Former Moderna SVP as New President

By

headshot of smiling man with gray hair
Image via Dr. Randall N. Hyer at LinkedIn.
Dr. Randall N. Hyer.

The Board of Directors for Doylestown’ Blumberg Institute has named Dr. Randall N. Hyer as its new president. Hyer, a former executive with Moderna, replaces Timothy Block, Blumberg’s founding president. John George covered the executive handoff in the Philadelphia Business Journal.

Hyer reports to duty July 1. He is a former senior vice president of global medical affairs at Moderna, Inc. From its Cambridge, Mass., headquarters he shepherded the company’s COVID-19 mRNA vaccine.

Assessing his replacement, Block said: “Dr. Hyer’s background makes him perfectly suited for this position, and I know he is a tremendous person and scientist.

“While it’s challenging, certainly, for me personally to hand over the reins, Randy brings a new passion and dedication to our mission that will build upon the momentum that exists in the Blumberg Institute.”

Hyer is eager to get going.

“From my first interactions with Dr. Block and the organizations he founded, I’ve been extremely impressed with their scientific rigor and their dedication to finding cures and treatments for hepatitis B, liver cancer and associated diseases,” he said. “The opportunity to serve as president of the Blumberg Institute is exciting and one I warmly and enthusiastically accept.”

More on the next phase of soon-to-be former Moderna executive Randall N. Hyer is at The Philadelphia Business Journal.

Connect With Your Community

Subscribe for stories that matter!

"*" indicates required fields

Hidden
BT Yes
This field is for validation purposes and should be left unchanged.
Advertisement